期刊文献+

糖尿病酮症酸中毒合并高淀粉酶血症的相关因素 被引量:2

The Analysis of the Correlative Factors about the Diabetes Mellitus Ketoacidosis and Hyperamylasemia
下载PDF
导出
摘要 目的:探讨无并发急性胰腺炎的糖尿痛酮症酸中毒患者血淀粉酶升高的相关因素。方法:421例糖尿病酮症酸中毒患者,根据诊断标准排除急性胰腺炎,检测血淀粉酶、钠、钾、氯、钙、磷、肌酐、二氧化碳结合力、葡萄糖,次晨空暖腹血脂、肝功能,淀粉酶升高者,每4~8小时复查血淀粉酶。以血淀粉酶为应变量,以血糖等14个自变量进行多元线性回归分析。结果:葡萄糖、血钠、血渗透压、血三酰甘油与血糖显著相关(P<0.05)。结论:糖尿病酮症酸中毒患者血淀粉酶升高的主要原因是脱水、高血糖、高三酰甘油、高血渗透压,高血钠是血淀粉酶升高的加重因素。 Objective:To study the correlationship among factors about the diabetes mellitus ketoacidosis and high hemodiastase without acute pancreatitis. Methods:We selected 421 patients who had suffered from diabetes mellitus ketoacidosis. Without acute pancreatitis according to the diagnostic criteria, serum hemodiastase, natrium, kalium, chlorine, calcium, phosphonium, creatinine,carbon dioxide combining power and blood glucose were measured. The next morning, fatty-acid, liver and renal function in fast were measured. Hemodiastase was repeated every 4 to 8 hours if their hemodiastase were high. We used hemodiastase as the dependent variable and the other 14 factors such as the blood glucose as the independent variable. The muhiple linear regression model was used were associated with hemodiastase. Results:The blood glucose, serum natrium, osmotic pressure and triglyceride all entered the regression equation. Conclusion: High blood glucose, high osmotic pressure, high triglyceride and the dehydration are correlative factors in diabetes mellitus ketoacidosis patients with hyperamylasemia. The serum natrium is an aggravation factor that promotes the hemodiastase.
出处 《中国临床医学》 北大核心 2007年第6期909-910,共2页 Chinese Journal of Clinical Medicine
关键词 糖尿病酮症酸中毒 高淀粉酶血症 Diabetes mellitus ketoacidosis Hyperamylasemia
  • 相关文献

参考文献5

  • 1中华医学会消化病学分会胰腺疾病学组.中国急性胰腺炎诊治指南(草案)[J].中华消化杂志,2004,24(3):190-192. 被引量:1765
  • 2张弛,周智广,张冬梅,杨晓琳,周敏,林健,黄干,王建平.急骤起病伴胰酶增高的1型糖尿病临床和免疫学特征[J].中华医学杂志,2005,85(14):967-971. 被引量:46
  • 3Satheesh N,Dbiraj Y. Pitchumoni CS, et al. Observations in 100 consecutive episodes of diabetic ketoacidosis[J]. The American Journal of Gastroenterology,2000,95:2495-2800.
  • 4唐炜立,超楚生.血脂异常症[A].见廖二元,超楚生,主编.内分泌学[M].北京:人民卫生出版社,2001:1695-1717.
  • 5Halonen KI.Peuilav, Leppaiemi AK, et al. Multiple organ dysfunction associated with severe acute pancreatitis[J]. Critl Care Med. 2002.3(1(6) : 1274.

二级参考文献19

  • 1Taniyama M, Katsumata R, Aoki K, et al. A Fillipino patient with fulminant type 1 diabetes. Diabetes Care, 2004, 27:842-843.
  • 2Imagawa A,- Hanafusa T, Uchigata Y, et al. Different contribution of class Ⅱ HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia,2005, 48:294-300.
  • 3Imagawa A, Hanafusa T, Makino H, et al. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia,2005, 48:290-293.
  • 4Yadav D, Nair S, Norkus EP, et al. Nonspecitic hyperamylasemia and hyperlipasemia in diabetic ketoacidosis: incidence and correlation with biochemical abnormalities. Am J Gastroenterol,2000, 95:3123-3128.
  • 5Semakula C, Vandewalle CL, Van Schravendijk CF, et al.Abnormal pancreatic enzyme activities in more than twenty-five percent recent onset insulin-dependent diabetic patients: association of hyperlipasemia with high titre islet-cell antibodies. Pancreas,1996,12:321-333.
  • 6Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 1997,20:1183-1197.
  • 7Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 : diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998, 15:539-553.
  • 8Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med, 2000, 342:301-307.
  • 9Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes. A nationwide survey in Japan. Diabetes Care, 2003, 26:2345-2352.
  • 10Maldonado MM, Hampe CS, Gaur LK, et al. Ketosis-Prone diabetes : dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab, 2003,88:5090-5098.

共引文献1809

同被引文献22

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部